BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32867272)

  • 1. Kinins and Their Receptors in Infectious Diseases.
    Dagnino APA; Campos MM; Silva RBM
    Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32867272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinins and their B
    Brusco I; Justino AB; Silva CR; Fischer S; Cunha TM; Scussel R; Machado-de-Ávila RA; Ferreira J; Oliveira SM
    Biochem Pharmacol; 2019 Oct; 168():119-132. PubMed ID: 31254493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system.
    Regoli D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S401-12. PubMed ID: 6206349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinins and kinin receptors in the nervous system.
    Walker K; Perkins M; Dray A
    Neurochem Int; 1995 Jan; 26(1):1-16; discussion 17-26. PubMed ID: 7787759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kallikrein-kinin system: current and future pharmacological targets.
    Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A
    J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide antagonists for kinin receptors.
    Altamura M; Meini S; Quartara L; Maggi CA
    Regul Pept; 1999 Mar; 80(1-2):13-26. PubMed ID: 10235630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level.
    Ferreira J; Campos MM; Araújo R; Bader M; Pesquero JB; Calixto JB
    Neuropharmacology; 2002 Dec; 43(7):1188-97. PubMed ID: 12504926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the kinin-forming system in the physiopathology of rheumatoid inflammation.
    Sharma JN
    Agents Actions Suppl; 1992; 38 ( Pt 3)():343-61. PubMed ID: 1334358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
    Campbell DJ; Kladis A; Briscoe TA; Zhuo J
    Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinin B1 receptor regulates muscle-specific E3 ligases expression and is involved in skeletal muscle mass control.
    Parreiras-E-Silva LT; Reis RI; Santos GA; Pires-Oliveira M; Pesquero JB; Gomes MD; Godinho RO; Costa-Neto CM
    Clin Sci (Lond); 2014 Aug; 127(3):185-94. PubMed ID: 24498923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinin receptors and their antagonists as novel therapeutic agents.
    Oztürk Y
    Curr Pharm Des; 2001 Jan; 7(2):135-61. PubMed ID: 11172705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension.
    Cayla C; Todiras M; Iliescu R; Saul VV; Gross V; Pilz B; Chai G; Merino VF; Pesquero JB; Baltatu OC; Bader M
    FASEB J; 2007 Jun; 21(8):1689-98. PubMed ID: 17289925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinin receptors as targets for cancer therapy.
    Figueroa CD; Ehrenfeld P; Bhoola KD
    Expert Opin Ther Targets; 2012 Mar; 16(3):299-312. PubMed ID: 22339271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy.
    Argañaraz GA; Silva JA; Perosa SR; Pessoa LG; Carvalho FF; Bascands JL; Bader M; da Silva Trindade E; Amado D; Cavalheiro EA; Pesquero JB; da Graça Naffah-Mazzacoratti M
    Brain Res; 2004 Apr; 1006(1):114-25. PubMed ID: 15047030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinins and their receptors in hyperalgesia.
    Dray A
    Can J Physiol Pharmacol; 1997 Jun; 75(6):704-12. PubMed ID: 9276152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice.
    Ferreira J; Campos MM; Pesquero JB; Araújo RC; Bader M; Calixto JB
    Neuropharmacology; 2001 Dec; 41(8):1006-12. PubMed ID: 11747905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.
    Nakhostine N; Ribuot C; Lamontagne D; Nadeau R; Couture R
    Br J Pharmacol; 1993 Sep; 110(1):71-6. PubMed ID: 8220916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for bradykinin and related kinins: a critical analysis.
    Regoli D; Jukic D; Gobeil F; Rhaleb NE
    Can J Physiol Pharmacol; 1993 Aug; 71(8):556-67. PubMed ID: 8306193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin receptors as a therapeutic target.
    Howl J; Payne SJ
    Expert Opin Ther Targets; 2003 Apr; 7(2):277-85. PubMed ID: 12667103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration.
    Bertram CM; Baltic S; Misso NL; Bhoola KD; Foster PS; Thompson PJ; Fogel-Petrovic M
    J Leukoc Biol; 2007 Jun; 81(6):1445-54. PubMed ID: 17327486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.